Author

J. Tien

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

A. Goodrum· 1 shared A. M. Chinnaiyan· 1 shared A. Maldonado-Contreras· 1 shared A. Xu· 1 shared B. Olendzki· 1 shared B. Singha· 1 shared C. F. Frisard· 1 shared C. Kumar-Sinha· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Goodrum

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Association of diet and inflammation with the vaginal microbiota of pregnant individuals with or without IBD

D. Vargas Robles, Y. Yan Rou, B. Singha, J. Tien, M. Purandare, M. Rojas-Correa, C. Madziar, M. Picker, T. Dumont, H. Leftwich, C. F. Frisard, D. V. Ward, I. Peter, B. Olendzki, A. Maldonado-Contreras

This study examines how diet and inflammation affect vaginal microbiota in pregnant individuals with or without IBD, finding that healthier diets correlate with higher Lactobacillus crispatus dominance.

bioRxiv · Apr 23, 2024 · PreprintMicrobiology

An Essential Role for Argonaute 2 in EGFR-KRAS Signaling in Pancreatic Cancer Development

S. Shankar, J. Tien, R. F. Siebenaler, S. Chugh, V. L. Dommeti, S. Zelenka-Wang, J. Waninger, K. M. Juckette, A. Xu, X.-M. Wang, M. Mody, S. Eyunni, A. Goodrum, G. Tsaloff, Y. Zhang, , A. M. Chinnaiyan

This study shows AGO2 is required for pancreatic cancer progression but not initiation, with its role dependent on mutant KRAS and EGFR signaling.

bioRxiv · Aug 1, 2019Cancer Biology